Daniel Janse

Chief Executive Officer at

Affyimmune Therapeutics, Inc.

Health Technology

Consumer Services

Commercial Services

Profile

Daniel Janse is currently the President & Chief Executive Officer at Affyimmune Therapeutics, Inc. He previously held positions as the Director at Cell Therapy Ltd. in 2011, Senior Director at Juno Therapeutics GmbH from 2016 to 2018, Managing Director at Northpond Ventures LLC in 2023, Senior Director at Johnson & Johnson Innovation from 2013 to 2016, Manager at McKinsey & Co., Inc. from 2008 to 2011, Investment Manager at Inventages Venture Capital Investment, Inc. from 2011 to 2013, and Chief Operating Officer at Arbor Biotechnologies, Inc. from 2020 to 2021.
Dr. Janse obtained his undergraduate degree from Brown University in 1998 and his doctorate degree from Harvard University in 2005.

Daniel Janse active positions

Companies	Position	Start
Affyimmune Therapeutics, Inc. Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease	Chief Executive Officer	15/07/2024

All active positions of Daniel Janse

Former positions of Daniel Janse

Companies	Position	End
Northpond Ventures LLC Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions.	Director/Board Member	01/01/2023
Arbor Biotechnologies, Inc. Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines	Chief Operating Officer	31/05/2021
Juno Therapeutics GmbH Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer	Private Equity Investor	31/07/2018
Johnson & Johnson Innovation LLC Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services	Private Equity Investor	30/09/2016
Inventages Venture Capital Investment, Inc Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements.	Corporate Officer/Principal	31/07/2013

See the detail of Daniel Janse's experience

Training of Daniel Janse

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Janse's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inventages Venture Capital Investment, Inc Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements.	Finance
Cell Therapy Ltd. Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm	Health Technology
Johnson & Johnson Innovation LLC Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services	Health Services
Juno Therapeutics GmbH Juno Therapeutics GmbH BiotechnologyHealth Technology Develops CAR-T therapy candidates for the treatment of various types of cancer	Health Technology
Arbor Biotechnologies, Inc. Arbor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines	Health Technology
Northpond Ventures LLC Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions.	Finance
Affyimmune Therapeutics, Inc. Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease	Commercial Services